Todd Verdoorn
2017
In 2017, Todd Verdoorn earned a total compensation of $345.9K as Chief Scientific Officer at DiaMedica Therapeutics.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Option Awards | $98,670 |
| Salary | $200,000 |
| Other | $7,200 |
| Total | $345,870 |
Verdoorn received $200K in salary, accounting for 58% of the total pay in 2017.
Verdoorn also received $40K in bonus, $98.7K in option awards and $7.2K in other compensation.
Rankings
In 2017, Todd Verdoorn's compensation ranked 12,989th out of 14,666 executives tracked by ExecPay. In other words, Verdoorn earned more than 11.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,989 out of 14,666 | 11th |
Division Manufacturing | 5,116 out of 5,772 | 11th |
Major group Chemicals And Allied Products | 1,865 out of 2,075 | 10th |
Industry group Drugs | 1,554 out of 1,731 | 10th |
Industry Pharmaceutical Preparations | 1,203 out of 1,333 | 10th |
Source: SEC filing on April 8, 2019.
Verdoorn's colleagues
We found one more compensation record of an executive who worked with Todd Verdoorn at DiaMedica Therapeutics in 2017.
2017
Rick Pauls
DiaMedica Therapeutics